Jan Ankar Monssen

Papers

Total Citations

H-Index

About

Jan Ankar Monssen is a clinical researcher whose work centers on improving risk stratification and surgical outcomes in prostate cancer, with a particular focus on integrating advanced imaging into preoperative decision-making. His most cited study, "Optimising preoperative risk stratification tools for prostate cancer using mpMRI" (2017, 22 citations), demonstrates a key contribution: systematically incorporating multiparametric MRI (mpMRI) features into established risk tools like CAPRA and D’Amico. By analyzing data from 807 consecutive patients undergoing robot-assisted radical prostatectomy, Monssen showed that adding mpMRI parameters significantly refines risk prediction, helping to better identify patients who may benefit from more aggressive treatment versus active surveillance. This work bridges radiology and urology, offering a practical, evidence-based pathway to personalize prostate cancer care. Monssen’s research is particularly valuable for clinicians seeking to reduce overtreatment while ensuring high-risk patients receive timely intervention. His findings have informed ongoing discussions about standardizing mpMRI integration into clinical guidelines, underscoring his role in advancing precision oncology.